scholarly journals 445PD ASCEND-6: single-arm, open label, multicenter phase 1/2 study of ceritinib in Chinese pts with advanced ALK- rearranged (ALK +) non-small cell lung cancer (NSCLC) previously treated with crizotinib

2016 ◽  
Vol 27 ◽  
pp. ix143
Author(s):  
L. Zhang ◽  
Y. Shi ◽  
D.S.W. Tan ◽  
B. Hu ◽  
L. Xiaoqing ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Multicenter Phase ◽  
Previously Treated

scholarly journals Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

2016 ◽  
Vol 17 (7) ◽  
pp. 883-895 ◽  
Author(s):  
Scott J Antonia ◽  
José A López-Martin ◽  
Johanna Bendell ◽  
Patrick A Ott ◽  
Matthew Taylor ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Phase

scholarly journals Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study

2020 ◽  
Vol 15 (3) ◽  
pp. 392-403 ◽  
Author(s):  
Enriqueta Felip ◽  
Filippo G. de Braud ◽  
Michela Maur ◽  
Herbert H. Loong ◽  
Alice Tsang Shaw ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Multicenter Phase ◽  
Phase 1B

Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study

2019 ◽  
Vol 7 (4) ◽  
pp. 347-357 ◽  
Author(s):  
Natasha B Leighl ◽  
Matthew D Hellmann ◽  
Rina Hui ◽  
Enric Carcereny ◽  
Enriqueta Felip ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 1 Study ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document